A federal judge is weighing a request from the Trump administration to unseal records of the FBI's surveillance of Martin ...

Amgen AMGN announced encouraging new data from its interim analysis of the global late-stage study evaluating Imdelltra ...

While the approval is a historic event for the BiTE drug class in solid tumours, the market share opportunity is restricted ...

A federal judge said it could take years to negotiate the release of any files related to the FBI's surveillance of the Rev. Martin Luther King Jr.

Trump executive order prompts request to release FBI wiretap records two years early, over objections by the civil rights group King founded and his children.

Amgen has detailed a positive phase 3 readout for its T-cell engager Imdelltra in previously treated small cell lung cancer ...

CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...

BMS will co-develop and co-commercialize BioNTech’s bispecific antibody BNT327 for solid tumors in a deal worth up to $11.1B ...

Analysts said the data suggest “a strong treatment effect.” Jazz has filed for FDA approval for the combination, which could ...

Phase 3 trial shows lurbinectedin plus atezolizumab significantly improves progression-free and overall survival in ES-SCLC ...

Jazz Pharma's Zepzelca plus Tecentriq significantly improved survival in a Phase 3 study for extensive-stage small-cell lung ...

A new study is the first phase 3 to show meaningful improvement in both progression-free and overall survival with first-line ...